Trulieve Cannabis (TSE:TRU – Get Free Report) was upgraded by research analysts at Craig Hallum to a “strong-buy” rating in a note issued to investors on Wednesday,Zacks.com reports.
Separately, Atb Cap Markets raised Trulieve Cannabis from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 9th.
Check Out Our Latest Research Report on TRU
Trulieve Cannabis Price Performance
Insider Transactions at Trulieve Cannabis
About Trulieve Cannabis
TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.
Recommended Stories
- Five stocks we like better than Trulieve Cannabis
- Growth Stocks: What They Are, Examples and How to Invest
- Salesforce’s Hidden Strengths Could Fuel a Powerful Rebound
- What is a Death Cross in Stocks?
- 3 Stocks With Unusual Call Option Volume – What It Signals
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Top 4 Healthcare REITs Turning Care Into Big Investor Payouts
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.